Ani Pharmaceuticals Book Value Per Share Growth & History (ANIP)
Ani Pharmaceuticals's book value per share was $24.04 for fiscal 2025.
View full Ani Pharmaceuticals company overviewAni Pharmaceuticals annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24.04 | $4.92 | +25.71% |
| 2024 | 2024-12-31 | $19.12 | -$2.02 | −9.55% |
| 2023 | 2023-12-31 | $21.14 | $3.21 | +17.92% |
| 2022 | 2022-12-31 | $17.93 | -$6.60 | −26.92% |
| 2021 | 2021-12-31 | $24.53 | $8.18 | +49.99% |
| 2020 | 2020-12-31 | $16.36 | -$1.61 | −8.98% |
| 2019 | 2019-12-31 | $17.97 | $1.08 | +6.38% |
| 2018 | 2018-12-31 | $16.89 | $1.76 | +11.62% |
| 2017 | 2017-12-31 | $15.13 | $0.31 | +2.10% |
| 2016 | 2016-12-31 | $14.82 | $0.74 | +5.28% |
| 2015 | 2015-12-31 | $14.08 | $1.30 | +10.20% |
| 2014 | 2014-12-31 | $12.78 | $4.70 | +58.17% |
| 2013 | 2013-12-31 | $8.08 | $9.83 | — |
| 2012 | 2012-12-31 | -$1.75 | -$1.47 | — |
| 2011 | 2011-12-31 | -$0.28 | -$2.03 | — |
| 2010 | 2010-12-31 | $1.74 | $1.28 | +273.82% |
| 2009 | 2009-12-31 | $0.47 | — | — |
Ani Pharmaceuticals quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26.00 | $5.89 | +29.29% |
| Q1 2026 | 2026-03-31 | $24.58 | $3.23 | +15.12% |
| Q4 2025 | 2025-12-31 | $24.04 | $4.92 | +25.71% |
| Q3 2025 | 2025-09-30 | $22.52 | $1.60 | +7.64% |
| Q2 2025 | 2025-06-30 | $20.11 | -$3.48 | −14.76% |
| Q1 2025 | 2025-03-31 | $21.35 | -$2.31 | −9.78% |
| Q4 2024 | 2024-12-31 | $19.12 | — | — |
| Q3 2024 | 2024-09-30 | $20.92 | -$1.84 | −8.10% |
| Q2 2024 | 2024-06-30 | $23.59 | $0.43 | +1.86% |
| Q1 2024 | 2024-03-31 | $23.66 | $4.47 | +23.29% |
| Q3 2023 | 2023-09-30 | $22.76 | $3.64 | +19.02% |
| Q2 2023 | 2023-06-30 | $23.16 | $3.98 | +20.74% |
| Q1 2023 | 2023-03-31 | $19.19 | -$0.71 | −3.58% |
| Q3 2022 | 2022-09-30 | $19.13 | $3.32 | +20.98% |
| Q2 2022 | 2022-06-30 | $19.18 | $3.30 | +20.78% |
| Q1 2022 | 2022-03-31 | $19.91 | $2.94 | +17.31% |
| Q3 2021 | 2021-09-30 | $15.81 | -$0.46 | −2.83% |
| Q2 2021 | 2021-06-30 | $15.88 | -$0.11 | −0.68% |
| Q1 2021 | 2021-03-31 | $16.97 | $0.07 | +0.40% |
| Q3 2020 | 2020-09-30 | $16.27 | -$1.67 | −9.31% |
| Q2 2020 | 2020-06-30 | $15.99 | -$1.53 | −8.75% |
| Q1 2020 | 2020-03-31 | $16.90 | -$0.10 | −0.58% |
| Q3 2019 | 2019-09-30 | $17.94 | $1.50 | +9.12% |
| Q2 2019 | 2019-06-30 | $17.52 | $1.67 | +10.55% |
| Q1 2019 | 2019-03-31 | $17.00 | $1.50 | +9.68% |
| Q3 2018 | 2018-09-30 | $16.44 | $0.62 | +3.91% |
| Q2 2018 | 2018-06-30 | $15.85 | $0.56 | +3.66% |
| Q1 2018 | 2018-03-31 | $15.50 | $0.56 | +3.76% |
| Q3 2017 | 2017-09-30 | $15.82 | $1.10 | +7.45% |
| Q2 2017 | 2017-06-30 | $15.29 | $0.93 | +6.45% |
| Q1 2017 | 2017-03-31 | $14.94 | $0.88 | +6.28% |
| Q3 2016 | 2016-09-30 | $14.73 | $1.03 | +7.53% |
| Q2 2016 | 2016-06-30 | $14.36 | $1.19 | +8.99% |
| Q1 2016 | 2016-03-31 | $14.06 | $1.28 | +10.00% |
| Q3 2015 | 2015-09-30 | $13.69 | $4.84 | +54.64% |
| Q2 2015 | 2015-06-30 | $13.18 | $5.02 | +61.62% |
| Q1 2015 | 2015-03-31 | $12.78 | $3.56 | +38.64% |
| Q3 2014 | 2014-09-30 | $8.86 | $4.99 | +128.82% |
| Q2 2014 | 2014-06-30 | $8.15 | -$22.63 | −73.51% |
| Q1 2014 | 2014-03-31 | $9.22 | $8.15 | +767.10% |
| Q3 2013 | 2013-09-30 | $3.87 | $2.46 | +174.73% |
| Q2 2013 | 2013-06-30 | $30.78 | $29.37 | +2082.50% |
| Q1 2013 | 2013-03-31 | $1.06 | $0.74 | +225.28% |
| Q4 2012 | 2012-12-31 | -$1.75 | -$1.47 | — |
| Q3 2012 | 2012-09-30 | $1.41 | -$1.13 | −44.46% |
| Q2 2012 | 2012-06-30 | $1.41 | $0.67 | +91.62% |
| Q1 2012 | 2012-03-31 | $0.33 | — | — |
| Q4 2011 | 2011-12-31 | -$0.28 | — | — |
| Q3 2011 | 2011-09-30 | $2.54 | — | — |
| Q2 2011 | 2011-06-30 | $0.74 | — | — |
Ani Pharmaceuticals book value per share trends
Over the last five fiscal years, Ani Pharmaceuticals's book value per share increased from $16.36 to $24.04, a change of $7.68. The latest reported quarter, Q2 2026, shows $26.00.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ani Pharmaceuticals source filings ↗